award

Novel proteasome inhibitors targeting both beta5 and beta2 subunits for treatment of triple negative breast cancer

  • Award Number: R01CA276053

  • ORGANIZATION: NATIONAL CANCER INSTITUTE

  • OPDIV: NIH

  • AWARD CLASS: DISCRETIONARY

  • AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

  • PERIOD OF PERFORMANCE START DATE: 02/22/2024

  • PERIOD OF PERFORMANCE END DATE: 12/31/2028